Policy & News
The 2nd one in China! Kexing EV71-CA16 Bivalent HFMD Vaccine Approved for Clinical Use
2023-07-19
On 17 July, SINOVAC Kexing's official microblogging news said that the National Drug Administration (NMPA) has recently approved the application for clinical trials of the bivalent inactivated enterovirus vaccine (Vero cell), a new drug in the category of preventive biologics 1 developed by Beijing Kexing Biological Products Company Limited under the banner of SINOVAC Kexing, which is used for the prevention of diseases caused by infection by two viruses of enterovirus 71 (EV71) and coxsackievirus 16 (CA16).
Latest News
Promoting Integration with Competitions and Showing Style
The first badminton match of "Kangrun Cup" was successfully held.
Building Elites with Aggressiveness and Winning the Future with Concentration and Effort
Jiangsu Kangrun Biotechnology Co., Ltd. 2023 New Employee Expansion Activities Successfully Conducted
Pre season talk about influenza vaccines: correct cognition without hesitation
Luwang, September 11th (Reporter Guan Xiaohui, Correspondent Li Chengxiu, Ma Jin) Influenza is an acute respiratory infectious disease caused by the influenza virus that poses a threat to human health. It is seasonal (commonly known as the "flu season") and can cause serious complications such as pneumonia, encephalitis, and even death in infants, young children, and the elderly. Therefore, outbreaks of COVID-19 are prone to occur in schools, kindergartens, and elderly care institutions. Although there was a nationwide outbreak of H1N1 influenza A from February to April this year, according to perennial epidemiological data in China, the southern and northern regions generally have a high incidence in winter and spring (November to February of the following year), and the areas south of the Yangtze River can also have a high incidence in summer. Therefore, we are currently in the pre flu season, which is the best time to receive influenza vaccines, especially for infants, young children, primary and secondary school students, the elderly, medical personnel, and entry-exit port staff. However, due to cognitive differences, some parents and vaccination populations have varying degrees of hesitation in vaccination, mostly suspecting the effective protection of the vaccine, followed by anxiety about vaccination safety. For this, let's talk about topics related to influenza vaccines together.
